Yasutaka Chiba Selected Research

Yasutaka Chiba Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 07/2011
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 08/2010
7	Stomach Neoplasms (Stomach Cancer) 07/2020 - 12/2012
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2012
4	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 06/2011
4	Pain (Aches) 08/2023 - 09/2017
4	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2016
4	Lung Neoplasms (Lung Cancer) 01/2023 - 05/2016
3	Cancer Pain 08/2023 - 10/2017
3	Esophageal Squamous Cell Carcinoma 04/2023 - 01/2019
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 08/2013
3	Pathologic Constriction (Stenosis) 01/2018 - 11/2016
2	Adenocarcinoma 11/2023 - 07/2019
2	Vomiting 01/2023 - 01/2020
2	Nausea 01/2023 - 01/2020
2	Obstructive Jaundice (Cholestatic Jaundice) 11/2022 - 02/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2019
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 10/2020 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 12/2015
2	Asthma (Bronchial Asthma) 07/2020 - 03/2013
2	Osteoporosis 11/2019 - 06/2015
2	Duodenal Obstruction 02/2016 - 02/2016
2	Cholestasis 02/2016 - 02/2016
2	Insulin Resistance 06/2015 - 01/2015
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Neoplasm Micrometastasis 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2015
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2017
8	NivolumabIBA 01/2023 - 11/2017
8	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2015
6	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 10/2018
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 05/2012
5	LigandsIBA 08/2023 - 01/2015
5	Docetaxel (Taxotere)FDA Link 04/2023 - 01/2019
5	AfatinibIBA 01/2023 - 11/2017
4	Immune Checkpoint InhibitorsIBA 04/2024 - 03/2018
4	Carboplatin (JM8)FDA LinkGeneric 03/2022 - 07/2011
3	Immune Checkpoint ProteinsIBA 04/2024 - 01/2018
3	B7-H1 AntigenIBA 04/2024 - 01/2022
3	Opioid Analgesics (Opioids)IBA 08/2023 - 10/2017
3	Oxycodone (Oxycontin)FDA LinkGeneric 08/2023 - 10/2017
3	Morphine (MS Contin)FDA LinkGeneric 08/2023 - 10/2017
3	Fluorouracil (Carac)FDA LinkGeneric 04/2023 - 01/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 06/2011
3	osimertinibIBA 01/2023 - 02/2019
3	Neuregulin-1 (Neuregulin 1)IBA 12/2019 - 01/2015
2	durvalumabIBA 03/2024 - 10/2023
2	130-nm albumin-bound paclitaxelIBA 09/2023 - 01/2021
2	Gemcitabine FDA Link 09/2023 - 12/2021
2	AntigensIBA 01/2023 - 01/2022
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 10/2017
2	pembrolizumabIBA 01/2023 - 10/2021
2	Pemetrexed (MTA)FDA Link 03/2022 - 11/2017
2	Oxygen (Dioxygen)IBA 10/2020 - 12/2015
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 06/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	trifluridine tipiracil drug combinationIBA 11/2023
1	Bevacizumab (Avastin)FDA Link 11/2023
1	ChemokinesIBA 08/2023
1	Analgesics (Analgesic Drugs)IBA 08/2023
1	Histamine N-MethyltransferaseIBA 08/2023
1	AntiemeticsIBA 01/2023
1	Olanzapine (Zyprexa)FDA Link 01/2023
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	PlasticsIBA 11/2022
1	MetalsIBA 11/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	patritumab deruxtecanIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cancer VaccinesIBA 01/2022
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2022
1	UracilIBA 12/2021
1	TegafurIBA 12/2021
1	perfluorobutane (AI 700)IBA 01/2021

Therapy/Procedure

23	Therapeutics 04/2024 - 07/2012
15	Drug Therapy (Chemotherapy) 11/2023 - 08/2010
9	Stents 11/2022 - 02/2016
6	Radiotherapy 06/2021 - 08/2010
4	Chemoradiotherapy 03/2024 - 05/2012
4	Neoadjuvant Therapy 04/2023 - 01/2019
2	Immunotherapy 01/2019 - 01/2018
2	TP protocol 10/2018 - 10/2018
2	Duration of Therapy 09/2017 - 06/2011
2	Choledochostomy 02/2016 - 02/2016
1	Adjuvant Chemotherapy 04/2024
1	Colectomy 01/2023
1	Palliative Care (Palliative Therapy) 01/2023
1	Self Expandable Metallic Stents 01/2021